590 Applications in Immunology and Immunotherapy


Description:
This session highlights applying both conventional and emerging systems concepts from biochemical engineering to aid in understanding immunology and developing immunotherapies. Presentations are invited on the latest developments that have direct relevance to immunology/immunotherapy: (1) experimental approaches that measure immune molecules and immune cell functions including the applications of –omics technologies, (2) molecular engineering, (3) design of next generation assays and (4) computational approaches to analyze, model or predict behavior.

Sponsor:
Engineering Fundamentals in Life Science


Chair:
Steven M. Abel
Assistant Professor
University of Tennessee
Chemical & Biomolecular Engineering
Knoxville, TN
02138
Phone Number: (865) 974-5709
Email: abel@utk.edu

Co-Chair:
Fei Wen
Dow Corning Assistant Professor
University of Michigan
Department of Chemical Engineering
219 RAL, Box C-3 RAL, MC-712
Ann Arbor, MI
61801
Email: feiwenum@umich.edu


Papers:
590a
Engineering Selective Immunoglobulin E Inhibitors for Peanut Allergies
Peter Deak, University of Notre Dame; Baksun Kim, University of Notre Dame; Maura Vrabel, University of Notre Dame; Joseph Riehm, University of Notre Dame; Tanyel Kiziltepe, University of Notre Dame; Basar Bilgicer, University of Notre Dame
590b
Glycan-Specific Antibody Discovery through Designer Glycopeptide Immunization
Tyler D. Moeller, Cornell University; Matthew P. DeLisa, Cornell University
590c
Localized Multi-Component Delivery Platform Generates Local and Systemic Anti-Tumor Immunity
Abhinav P. Acharya, University of Pittsburgh; Steven R. Little, University of Pittsburgh
590d
Microsphere-Assisted Peptide Screening (MAPs): High-Throughput Identification of Promiscuous MHCII-Binding Peptides for T-Cell Epitope Vaccine Designs
Mason Smith, University of Michigan; Fei Wen, University of Michigan
590e
Kinetic Analysis of CD3ζ and CD28 Chimeric Antigen Receptor T Cell Activation
Jennifer A. Rohrs, University of Southern California; Dongqing Zheng, University of Southern California; Nicholas Graham, University of Southern California; Pin Wang, University of Southern California; Stacey D. Finley, University of Southern California
590f
Catch Bonds at T Cell Interfaces
Robert H. Pullen III, University of Tennessee; Steven M. Abel, University of Tennessee
590g
Marrow-Derived & Surface-Engineered Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors
Dennis E. Discher, University of Pennsylvania
Abstract Submissions Closed
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
<< Previous Session | Next Session >>